Global Transdermal Drug Patches Market Growth 2021-2026
According to this latest study, the 2021 growth of Transdermal Drug Patches will have significant change from previous year. By the most conservative estimates of global Transdermal Drug Patches market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Transdermal Drug Patches market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hypertension
Contraception
Analgesia
Smoking Cessation
Angina
Hormone Replacement
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Noven
Mylan
Novartis
Johnson & Johnson
Agile Therapeutics
Teikoku Pharma USA
Immune Pharmaceuticals
Hercon Pharmaceuticals
Pocono
DURECT Corporation
Xel Pharmaceuticals
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transdermal Drug Patches Consumption 2016-2026
2.1.2 Transdermal Drug Patches Consumption CAGR by Region
2.2 Transdermal Drug Patches Segment by Type
2.2.1 Fentanyl Transdermal Patch
2.2.2 Nicotine Transdermal Patch
2.2.3 Buprenorphine Transdermal Patch
2.2.4 Clonidine Transdermal Patch
2.2.5 Oxybutynin Transdermal Patch
2.2.6 Others
2.3 Transdermal Drug Patches Sales by Type
2.3.1 Global Transdermal Drug Patches Sales Market Share by Type (2016-2021)
2.3.2 Global Transdermal Drug Patches Revenue and Market Share by Type (2016-2021)
2.3.3 Global Transdermal Drug Patches Sale Price by Type (2016-2021)
2.4 Transdermal Drug Patches Segment by Application
2.4.1 Hypertension
2.4.2 Contraception
2.4.3 Analgesia
2.4.4 Smoking Cessation
2.4.5 Angina
2.4.6 Hormone Replacement
2.5 Transdermal Drug Patches Sales by Application
2.5.1 Global Transdermal Drug Patches Sale Market Share by Application (2016-2021)
2.5.2 Global Transdermal Drug Patches Revenue and Market Share by Application (2016-2021)
2.5.3 Global Transdermal Drug Patches Sale Price by Application (2016-2021)
3 Global Transdermal Drug Patches by Company
3.1 Global Transdermal Drug Patches Sales Market Share by Company
3.1.1 Global Transdermal Drug Patches Sales by Company (2019-2021)
3.1.2 Global Transdermal Drug Patches Sales Market Share by Company (2019-2021)
3.2 Global Transdermal Drug Patches Revenue Market Share by Company
3.2.1 Global Transdermal Drug Patches Revenue by Company (2019-2021)
3.2.2 Global Transdermal Drug Patches Revenue Market Share by Company (2019-2021)
3.3 Global Transdermal Drug Patches Sale Price by Company
3.4 Global Manufacturers Transdermal Drug Patches Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Transdermal Drug Patches Product Location Distribution
3.4.2 Players Transdermal Drug Patches Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Transdermal Drug Patches by Region
4.1 Global Transdermal Drug Patches by Region
4.1.1 Global Transdermal Drug Patches Sales by Region
4.1.2 Global Transdermal Drug Patches Revenue by Region
4.2 Americas Transdermal Drug Patches Sales Growth
4.3 APAC Transdermal Drug Patches Sales Growth
4.4 Europe Transdermal Drug Patches Sales Growth
4.5 Middle East & Africa Transdermal Drug Patches Sales Growth
5 Americas
5.1 Americas Transdermal Drug Patches Sales by Country
5.1.1 Americas Transdermal Drug Patches Sales by Country (2016-2021)
5.1.2 Americas Transdermal Drug Patches Revenue by Country (2016-2021)
5.2 Americas Transdermal Drug Patches Sales by Type
5.3 Americas Transdermal Drug Patches Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transdermal Drug Patches Sales by Region
6.1.1 APAC Transdermal Drug Patches Sales by Region (2016-2021)
6.1.2 APAC Transdermal Drug Patches Revenue by Region (2016-2021)
6.2 APAC Transdermal Drug Patches Sales by Type
6.3 APAC Transdermal Drug Patches Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transdermal Drug Patches by Country
7.1.1 Europe Transdermal Drug Patches Sales by Country (2016-2021)
7.1.2 Europe Transdermal Drug Patches Revenue by Country (2016-2021)
7.2 Europe Transdermal Drug Patches Sales by Type
7.3 Europe Transdermal Drug Patches Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transdermal Drug Patches by Country
8.1.1 Middle East & Africa Transdermal Drug Patches Sales by Country (2016-2021)
8.1.2 Middle East & Africa Transdermal Drug Patches Revenue by Country (2016-2021)
8.2 Middle East & Africa Transdermal Drug Patches Sales by Type
8.3 Middle East & Africa Transdermal Drug Patches Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Transdermal Drug Patches Distributors
10.3 Transdermal Drug Patches Customer
11 Global Transdermal Drug Patches Market Forecast
11.1 Global Transdermal Drug Patches Forecast by Region
11.1.1 Global Transdermal Drug Patches Forecast by Regions (2021-2026)
11.2.2 Global Transdermal Drug Patches Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Transdermal Drug Patches Forecast by Type
11.7 Global Transdermal Drug Patches Forecast by Application
12 Key Players Analysis
12.1 Noven
12.1.1 Noven Company Information
12.1.2 Noven Transdermal Drug Patches Product Offered
12.1.3 Noven Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Noven Main Business Overview
12.1.5 Noven Latest Developments
12.2 Mylan
12.2.1 Mylan Company Information
12.2.2 Mylan Transdermal Drug Patches Product Offered
12.2.3 Mylan Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Mylan Main Business Overview
12.2.5 Mylan Latest Developments
12.3 Novartis
12.3.1 Novartis Company Information
12.3.2 Novartis Transdermal Drug Patches Product Offered
12.3.3 Novartis Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Novartis Main Business Overview
12.3.5 Novartis Latest Developments
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Information
12.4.2 Johnson & Johnson Transdermal Drug Patches Product Offered
12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Johnson & Johnson Main Business Overview
12.4.5 Johnson & Johnson Latest Developments
12.5 Agile Therapeutics
12.5.1 Agile Therapeutics Company Information
12.5.2 Agile Therapeutics Transdermal Drug Patches Product Offered
12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Agile Therapeutics Main Business Overview
12.5.5 Agile Therapeutics Latest Developments
12.6 Teikoku Pharma USA
12.6.1 Teikoku Pharma USA Company Information
12.6.2 Teikoku Pharma USA Transdermal Drug Patches Product Offered
12.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Teikoku Pharma USA Main Business Overview
12.6.5 Teikoku Pharma USA Latest Developments
12.7 Immune Pharmaceuticals
12.7.1 Immune Pharmaceuticals Company Information
12.7.2 Immune Pharmaceuticals Transdermal Drug Patches Product Offered
12.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Immune Pharmaceuticals Main Business Overview
12.7.5 Immune Pharmaceuticals Latest Developments
12.8 Hercon Pharmaceuticals
12.8.1 Hercon Pharmaceuticals Company Information
12.8.2 Hercon Pharmaceuticals Transdermal Drug Patches Product Offered
12.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Hercon Pharmaceuticals Main Business Overview
12.8.5 Hercon Pharmaceuticals Latest Developments
12.9 Pocono
12.9.1 Pocono Company Information
12.9.2 Pocono Transdermal Drug Patches Product Offered
12.9.3 Pocono Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Pocono Main Business Overview
12.9.5 Pocono Latest Developments
12.10 DURECT Corporation
12.10.1 DURECT Corporation Company Information
12.10.2 DURECT Corporation Transdermal Drug Patches Product Offered
12.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 DURECT Corporation Main Business Overview
12.10.5 DURECT Corporation Latest Developments
12.11 Xel Pharmaceuticals
12.11.1 Xel Pharmaceuticals Company Information
12.11.2 Xel Pharmaceuticals Transdermal Drug Patches Product Offered
12.11.3 Xel Pharmaceuticals Transdermal Drug Patches Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Xel Pharmaceuticals Main Business Overview
12.11.5 Xel Pharmaceuticals Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Transdermal Drug Patches Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Fentanyl Transdermal Patch
Table 3. Major Players of Nicotine Transdermal Patch
Table 4. Major Players of Buprenorphine Transdermal Patch
Table 5. Major Players of Clonidine Transdermal Patch
Table 6. Major Players of Oxybutynin Transdermal Patch
Table 7. Major Players of Others
Table 8. Global Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)
Table 9. Global Transdermal Drug Patches Sales Market Share by Type (2016-2021)
Table 10. Global Transdermal Drug Patches Revenue by Type (2016-2021) & ($ million)
Table 11. Global Transdermal Drug Patches Revenue Market Share by Type (2016-2021)
Table 12. Global Transdermal Drug Patches Sale Price by Type (2016-2021)
Table 13. Global Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)
Table 14. Global Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Table 15. Global Transdermal Drug Patches Value by Application (2016-2021)
Table 16. Global Transdermal Drug Patches Revenue Market Share by Application (2016-2021)
Table 17. Global Transdermal Drug Patches Sale Price by Application (2016-2021)
Table 18. Global Transdermal Drug Patches Sales by Company (2019-2021) & (K Units)
Table 19. Global Transdermal Drug Patches Sales Market Share by Company (2019-2021)
Table 20. Global Transdermal Drug Patches Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Transdermal Drug Patches Revenue Market Share by Company (2019-2021)
Table 22. Global Transdermal Drug Patches Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Transdermal Drug Patches Producing Area Distribution and Sales Area
Table 24. Players Transdermal Drug Patches Products Offered
Table 25. Transdermal Drug Patches Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Transdermal Drug Patches Sales by Region (2016-2021) (K Units)
Table 29. Global Transdermal Drug Patches Sales Market Share by Region (2016-2021)
Table 30. Global Transdermal Drug Patches Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Transdermal Drug Patches Revenue Market Share by Region (2016-2021)
Table 32. Americas Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)
Table 33. Americas Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 34. Americas Transdermal Drug Patches Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 36. Americas Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)
Table 37. Americas Transdermal Drug Patches Sales Market Share by Type (2016-2021)
Table 38. Americas Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)
Table 39. Americas Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Table 40. APAC Transdermal Drug Patches Sales by Region (2016-2021) & (K Units)
Table 41. APAC Transdermal Drug Patches Sales Market Share by Region (2016-2021)
Table 42. APAC Transdermal Drug Patches Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Transdermal Drug Patches Revenue Market Share by Region (2016-2021)
Table 44. APAC Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)
Table 45. APAC Transdermal Drug Patches Sales Market Share by Type (2016-2021)
Table 46. APAC Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)
Table 47. APAC Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Table 48. Europe Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)
Table 49. Europe Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 50. Europe Transdermal Drug Patches Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 52. Europe Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)
Table 53. Europe Transdermal Drug Patches Sales Market Share by Type (2016-2021)
Table 54. Europe Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)
Table 55. Europe Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Transdermal Drug Patches Sales by Country (2016-2021) & (K Units)
Table 57. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Transdermal Drug Patches Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Transdermal Drug Patches Sales by Type (2016-2021) & (K Units)
Table 61. Middle East & Africa Transdermal Drug Patches Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Transdermal Drug Patches Sales by Application (2016-2021) & (K Units)
Table 63. Middle East & Africa Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Table 64. Key and Potential Regions of Transdermal Drug Patches
Table 65. Key Application and Potential Industries of Transdermal Drug Patches
Table 66. Key Challenges of Transdermal Drug Patches
Table 67. Key Trends of Transdermal Drug Patches
Table 68. Transdermal Drug Patches Distributors List
Table 69. Transdermal Drug Patches Customer List
Table 70. Global Transdermal Drug Patches Sales Forecast by Region (2021-2026) & (K Units)
Table 71. Global Transdermal Drug Patches Consumption Market Forecast by Region
Table 72. Global Transdermal Drug Patches Revenue Forecast by Region (2021-2026) & ($ millions)
Table 73. Global Transdermal Drug Patches Revenue Market Share Forecast by Region (2021-2026)
Table 74. Americas Transdermal Drug Patches Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Americas Transdermal Drug Patches Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. APAC Transdermal Drug Patches Sales Forecast by Region (2021-2026) & (K Units)
Table 77. APAC Transdermal Drug Patches Revenue Forecast by Region (2021-2026) & ($ millions)
Table 78. Europe Transdermal Drug Patches Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Europe Transdermal Drug Patches Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Middle East & Africa Transdermal Drug Patches Sales Forecast by Country (2021-2026) & (K Units)
Table 81. Middle East & Africa Transdermal Drug Patches Revenue Forecast by Country (2021-2026) & ($ millions)
Table 82. Global Transdermal Drug Patches Sales Forecast by Type (2021-2026) & (K Units)
Table 83. Global Transdermal Drug Patches Sales Market Share Forecast by Type (2021-2026)
Table 84. Global Transdermal Drug Patches Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 85. Global Transdermal Drug Patches Revenue Market Share Forecast by Type (2021-2026)
Table 86. Global Transdermal Drug Patches Sales Forecast by Application (2021-2026) & (K Units)
Table 87. Global Transdermal Drug Patches Sales Market Share Forecast by Application (2021-2026)
Table 88. Global Transdermal Drug Patches Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 89. Global Transdermal Drug Patches Revenue Market Share Forecast by Application (2021-2026)
Table 90. Noven Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 91. Noven Transdermal Drug Patches Product Offered
Table 92. Noven Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 93. Noven Main Business
Table 94. Noven Latest Developments
Table 95. Mylan Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 96. Mylan Transdermal Drug Patches Product Offered
Table 97. Mylan Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 98. Mylan Main Business
Table 99. Mylan Latest Developments
Table 100. Novartis Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis Transdermal Drug Patches Product Offered
Table 102. Novartis Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 103. Novartis Main Business
Table 104. Novartis Latest Developments
Table 105. Johnson & Johnson Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 106. Johnson & Johnson Transdermal Drug Patches Product Offered
Table 107. Johnson & Johnson Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Latest Developments
Table 110. Agile Therapeutics Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 111. Agile Therapeutics Transdermal Drug Patches Product Offered
Table 112. Agile Therapeutics Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 113. Agile Therapeutics Main Business
Table 114. Agile Therapeutics Latest Developments
Table 115. Teikoku Pharma USA Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 116. Teikoku Pharma USA Transdermal Drug Patches Product Offered
Table 117. Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 118. Teikoku Pharma USA Main Business
Table 119. Teikoku Pharma USA Latest Developments
Table 120. Immune Pharmaceuticals Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 121. Immune Pharmaceuticals Transdermal Drug Patches Product Offered
Table 122. Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 123. Immune Pharmaceuticals Main Business
Table 124. Immune Pharmaceuticals Latest Developments
Table 125. Hercon Pharmaceuticals Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 126. Hercon Pharmaceuticals Transdermal Drug Patches Product Offered
Table 127. Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 128. Hercon Pharmaceuticals Main Business
Table 129. Hercon Pharmaceuticals Latest Developments
Table 130. Pocono Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 131. Pocono Transdermal Drug Patches Product Offered
Table 132. Pocono Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 133. Pocono Main Business
Table 134. Pocono Latest Developments
Table 135. DURECT Corporation Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 136. DURECT Corporation Transdermal Drug Patches Product Offered
Table 137. DURECT Corporation Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 138. DURECT Corporation Main Business
Table 139. DURECT Corporation Latest Developments
Table 140. Xel Pharmaceuticals Basic Information, Transdermal Drug Patches Manufacturing Base, Sales Area and Its Competitors
Table 141. Xel Pharmaceuticals Transdermal Drug Patches Product Offered
Table 142. Xel Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue ($ Million), Price (USD/K Units) and Gross Margin (2019-2021E)
Table 143. Xel Pharmaceuticals Main Business
Table 144. Xel Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Transdermal Drug Patches
Figure 2. Transdermal Drug Patches Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Transdermal Drug Patches Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Transdermal Drug Patches Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Transdermal Drug Patches Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Fentanyl Transdermal Patch
Figure 10. Product Picture of Nicotine Transdermal Patch
Figure 11. Product Picture of Buprenorphine Transdermal Patch
Figure 12. Product Picture of Clonidine Transdermal Patch
Figure 13. Product Picture of Oxybutynin Transdermal Patch
Figure 14. Product Picture of Others
Figure 15. Global Transdermal Drug Patches Sales Market Share by Type in 2020
Figure 16. Global Transdermal Drug Patches Revenue Market Share by Type (2016-2021)
Figure 17. Transdermal Drug Patches Consumed in Hypertension
Figure 18. Global Transdermal Drug Patches Market: Hypertension (2016-2021) & (K Units)
Figure 19. Transdermal Drug Patches Consumed in Contraception
Figure 20. Global Transdermal Drug Patches Market: Contraception (2016-2021) & (K Units)
Figure 21. Transdermal Drug Patches Consumed in Analgesia
Figure 22. Global Transdermal Drug Patches Market: Analgesia (2016-2021) & (K Units)
Figure 23. Transdermal Drug Patches Consumed in Smoking Cessation
Figure 24. Global Transdermal Drug Patches Market: Smoking Cessation (2016-2021) & (K Units)
Figure 25. Transdermal Drug Patches Consumed in Angina
Figure 26. Global Transdermal Drug Patches Market: Angina (2016-2021) & (K Units)
Figure 27. Transdermal Drug Patches Consumed in Hormone Replacement
Figure 28. Global Transdermal Drug Patches Market: Hormone Replacement (2016-2021) & (K Units)
Figure 29. Global Transdermal Drug Patches Sales Market Share by Application (2016-2021)
Figure 30. Global Transdermal Drug Patches Revenue Market Share by Application in 2020
Figure 31. Transdermal Drug Patches Revenue Market by Company in 2020 ($ Million)
Figure 32. Global Transdermal Drug Patches Revenue Market Share by Company in 2020
Figure 33. Global Transdermal Drug Patches Sales Market Share by Regions (2016-2021)
Figure 34. Global Transdermal Drug Patches Revenue Market Share by Region in 2020
Figure 35. Americas Transdermal Drug Patches Sales 2016-2021 (K Units)
Figure 36. Americas Transdermal Drug Patches Revenue 2016-2021 ($ Millions)
Figure 37. APAC Transdermal Drug Patches Sales 2016-2021 (K Units)
Figure 38. APAC Transdermal Drug Patches Revenue 2016-2021 ($ Millions)
Figure 39. Europe Transdermal Drug Patches Sales 2016-2021 (K Units)
Figure 40. Europe Transdermal Drug Patches Revenue 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Transdermal Drug Patches Sales 2016-2021 (K Units)
Figure 42. Middle East & Africa Transdermal Drug Patches Revenue 2016-2021 ($ Millions)
Figure 43. Americas Transdermal Drug Patches Sales Market Share by Country in 2020
Figure 44. Americas Transdermal Drug Patches Revenue Market Share by Country in 2020
Figure 45. Americas Transdermal Drug Patches Sales Market Share by Type in 2020
Figure 46. Americas Transdermal Drug Patches Sales Market Share by Application in 2020
Figure 47. United States Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 48. Canada Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 49. Mexico Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 50. Brazil Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 51. APAC Transdermal Drug Patches Sales Market Share by Region in 2020
Figure 52. APAC Transdermal Drug Patches Revenue Market Share by Regions in 2020
Figure 53. APAC Transdermal Drug Patches Sales Market Share by Type in 2020
Figure 54. APAC Transdermal Drug Patches Sales Market Share by Application in 2020
Figure 55. China Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 56. Japan Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 57. Korea Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 58. Southeast Asia Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 59. India Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 60. Australia Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 61. Europe Transdermal Drug Patches Sales Market Share by Country in 2020
Figure 62. Europe Transdermal Drug Patches Revenue Market Share by Country in 2020
Figure 63. Europe Transdermal Drug Patches Sales Market Share by Type in 2020
Figure 64. Europe Transdermal Drug Patches Sales Market Share by Application in 2020
Figure 65. Germany Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 66. France Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 67. UK Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 68. Italy Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 69. Russia Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 70. Middle East & Africa Transdermal Drug Patches Sales Market Share by Country in 2020
Figure 71. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Country in 2020
Figure 72. Middle East & Africa Transdermal Drug Patches Sales Market Share by Type in 2020
Figure 73. Middle East & Africa Transdermal Drug Patches Sales Market Share by Application in 2020
Figure 74. Egypt Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 75. South Africa Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 76. Israel Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 77. Turkey Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 78. GCC Country Transdermal Drug Patches Revenue Growth 2016-2021 ($ Millions)
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
